​
​

Bionomics Ownership 2024 | Who Owns Bionomics Now?

OverviewForecastRevenueFinancialsChart

Institutional Ownership

23.90%

Insider Ownership

55.91%

Retail Ownership

20.19%

Institutional Holders

13.00

Bionomics Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ARMISTICE CAPITAL, LLC12.93%0.01%1,226,7591,226,759100.00%940,924Jun 30, 2024
LYNX1 CAPITAL MANAGEMENT LP6.32%0.17%599,673-214,794-26.37%459,949Jun 30, 2024
POINT72 ASSET MANAGEMENT, L.P.3.33%0.00%316,000--242,372Jun 30, 2024
UBS GROUP AG0.37%-34,89724,964251.32%26,766Jun 30, 2024
TWO SIGMA SECURITIES, LLC0.27%0.00%26,03826,038100.00%19,971Jun 30, 2024
LEWIS ASSET MANAGEMENT, LLC0.24%0.01%23,0008,00053.33%17,641Jun 30, 2024
TWO SIGMA INVESTMENTS, LP0.17%-16,370-700-4.10%12,556Jun 30, 2024
XTX TOPCO LTD0.12%0.00%10,94010,940100.00%8,391Jun 30, 2024
BEACON POINTE ADVISORS, LLC0.11%0.00%10,000--7,670Jun 30, 2024
RHUMBLINE ADVISERS0.02%-2,19589068.20%1,682Jun 30, 2024
MORGAN STANLEY0.01%-794700744.68%609Jun 30, 2024
ASPIRE PRIVATE CAPITAL, LLC0.00%-200--153Jun 30, 2024
JPMORGAN CHASE & CO--1--1Jun 30, 2024

Bionomics's largest institutional shareholder is ARMISTICE CAPITAL, LLC, holding 12.93% of the company's total share outstanding, currently valued at $940.92K. The top 10 institutional shareholders own together 23.88% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
LYNX1 CAPITAL MANAGEMENT LP6.32%0.17%599,673-214,794-26.37%459,949Jun 30, 2024
LEWIS ASSET MANAGEMENT, LLC0.24%0.01%23,0008,00053.33%17,641Jun 30, 2024
ARMISTICE CAPITAL, LLC12.93%0.01%1,226,7591,226,759100.00%940,924Jun 30, 2024
XTX TOPCO LTD0.12%0.00%10,94010,940100.00%8,391Jun 30, 2024
POINT72 ASSET MANAGEMENT, L.P.3.33%0.00%316,000--242,372Jun 30, 2024
TWO SIGMA SECURITIES, LLC0.27%0.00%26,03826,038100.00%19,971Jun 30, 2024
BEACON POINTE ADVISORS, LLC0.11%0.00%10,000--7,670Jun 30, 2024
ASPIRE PRIVATE CAPITAL, LLC0.00%-200--153Jun 30, 2024
TWO SIGMA INVESTMENTS, LP0.17%-16,370-700-4.10%12,556Jun 30, 2024
UBS GROUP AG0.37%-34,89724,964251.32%26,766Jun 30, 2024
RHUMBLINE ADVISERS0.02%-2,19589068.20%1,682Jun 30, 2024
MORGAN STANLEY0.01%-794700744.68%609Jun 30, 2024
JPMORGAN CHASE & CO--1--1Jun 30, 2024

The largest Bionomics shareholder by % of total assets is LYNX1 CAPITAL MANAGEMENT LP. The company owns 599.67K shares of Bionomics (BNOX), representing 0.17% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ARMISTICE CAPITAL, LLC12.93%0.01%1,226,7591,226,759100.00%940,924Jun 30, 2024
TWO SIGMA SECURITIES, LLC0.27%0.00%26,03826,038100.00%19,971Jun 30, 2024
UBS GROUP AG0.37%-34,89724,964251.32%26,766Jun 30, 2024
XTX TOPCO LTD0.12%0.00%10,94010,940100.00%8,391Jun 30, 2024
LEWIS ASSET MANAGEMENT, LLC0.24%0.01%23,0008,00053.33%17,641Jun 30, 2024
RHUMBLINE ADVISERS0.02%-2,19589068.20%1,682Jun 30, 2024
MORGAN STANLEY0.01%-794700744.68%609Jun 30, 2024
JPMORGAN CHASE & CO--1--1Jun 30, 2024
ASPIRE PRIVATE CAPITAL, LLC0.00%-200--153Jun 30, 2024
BEACON POINTE ADVISORS, LLC0.11%0.00%10,000--7,670Jun 30, 2024
POINT72 ASSET MANAGEMENT, L.P.3.33%0.00%316,000--242,372Jun 30, 2024
TWO SIGMA INVESTMENTS, LP0.17%-16,370-700-4.10%12,556Jun 30, 2024
LYNX1 CAPITAL MANAGEMENT LP6.32%0.17%599,673-214,794-26.37%459,949Jun 30, 2024

As of Jun 30 2024, Bionomics's largest institutional buyer is ARMISTICE CAPITAL, LLC. The company purchased 1.23M stocks of BNOX, valued at $940.92K.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
LYNX1 CAPITAL MANAGEMENT LP6.32%0.17%599,673-214,794-26.37%459,949Jun 30, 2024
TWO SIGMA INVESTMENTS, LP0.17%-16,370-700-4.10%12,556Jun 30, 2024
POINT72 ASSET MANAGEMENT, L.P.3.33%0.00%316,000--242,372Jun 30, 2024
BEACON POINTE ADVISORS, LLC0.11%0.00%10,000--7,670Jun 30, 2024
ASPIRE PRIVATE CAPITAL, LLC0.00%-200--153Jun 30, 2024
JPMORGAN CHASE & CO--1--1Jun 30, 2024
MORGAN STANLEY0.01%-794700744.68%609Jun 30, 2024
RHUMBLINE ADVISERS0.02%-2,19589068.20%1,682Jun 30, 2024
LEWIS ASSET MANAGEMENT, LLC0.24%0.01%23,0008,00053.33%17,641Jun 30, 2024
XTX TOPCO LTD0.12%0.00%10,94010,940100.00%8,391Jun 30, 2024
UBS GROUP AG0.37%-34,89724,964251.32%26,766Jun 30, 2024
TWO SIGMA SECURITIES, LLC0.27%0.00%26,03826,038100.00%19,971Jun 30, 2024
ARMISTICE CAPITAL, LLC12.93%0.01%1,226,7591,226,759100.00%940,924Jun 30, 2024

As of Jun 30 2024, Bionomics's biggest institutional seller is LYNX1 CAPITAL MANAGEMENT LP. The company sold -0.21M shares of BNOX, valued at $459.95K.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ARMISTICE CAPITAL, LLC12.93%0.01%1,226,7591,226,759100.00%940,924Jun 30, 2024
TWO SIGMA SECURITIES, LLC0.27%0.00%26,03826,038100.00%19,971Jun 30, 2024

Bionomics's largest new institutional shareholder by number of shares is ARMISTICE CAPITAL, LLC, purchased 1.23M shares, valued at $940.92K, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate

Bionomics Institutional Ownership Trends

Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 241330.00%
31 Mar, 241011.11%
31 Dec, 239-18.18%
30 Sep, 2311266.67%
30 Jun, 233-
31 Mar, 233-40.00%
31 Dec, 22566.67%
30 Sep, 22350.00%
30 Jun, 222-33.33%
31 Mar, 223-40.00%
31 Dec, 215-

As of 30 Jun 24, 13 institutions are holding Bionomics's shares, representing an increase of 30.00% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 242,266,86791.45%
31 Mar, 241,184,070-8.64%
31 Dec, 231,296,018-46.32%
30 Sep, 232,414,424823.59%
30 Jun, 23261,417-1.04%
31 Mar, 23264,153-25.22%
31 Dec, 22353,25859.05%
30 Sep, 22222,1040.06%
30 Jun, 22221,978-44.39%
31 Mar, 22399,173-9.11%
31 Dec, 21439,206-

Bionomics (BNOX) has 2.27M shares outstanding as of 30 Jun 24, up 91.45% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 2423.90%15.34%
31 Mar, 2412.48%4.95%
31 Dec, 2315.88%1.54%
30 Sep, 2332.11%265.64%
30 Jun, 233.48%28.17%
31 Mar, 233.51%15.92%
31 Dec, 224.70%53.84%
30 Sep, 222.95%33.89%
30 Jun, 222.95%10.47%
31 Mar, 225.31%5.17%
31 Dec, 2110.14%-

As of 30 Jun 24, Bionomics is held by 23.90% institutional shareholders, representing a 15.34% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 24740.00%
31 Mar, 245-
31 Dec, 235-50.00%
30 Sep, 2310-
30 Jun, 23--
31 Mar, 23--100.00%
31 Dec, 223200.00%
30 Sep, 221-
30 Jun, 22--
31 Mar, 22--100.00%
31 Dec, 215-

7 institutional shareholders have increased their position in BNOX stock as of 30 Jun 24 compared to 5 in the previous quarter (a 40.00% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 242-50.00%
31 Mar, 244100.00%
31 Dec, 232100.00%
30 Sep, 231-50.00%
30 Jun, 232100.00%
31 Mar, 231-
31 Dec, 221-
30 Sep, 22--100.00%
30 Jun, 221-50.00%
31 Mar, 222-
31 Dec, 21--

2 institutional shareholders have reduced their position in BNOX stock as of 30 Jun 24 compared to 4 in the previous quarter (a -50.00% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 241330.00%2,266,86791.45%23.90%15.34%740.00%2-50.00%
31 Mar, 241011.11%1,184,070-8.64%12.48%4.95%5-4100.00%
31 Dec, 239-18.18%1,296,018-46.32%15.88%1.54%5-50.00%2100.00%
30 Sep, 2311266.67%2,414,424823.59%32.11%265.64%10-1-50.00%
30 Jun, 233-261,417-1.04%3.48%28.17%--2100.00%
31 Mar, 233-40.00%264,153-25.22%3.51%15.92%--100.00%1-
31 Dec, 22566.67%353,25859.05%4.70%53.84%3200.00%1-
30 Sep, 22350.00%222,1040.06%2.95%33.89%1---100.00%
30 Jun, 222-33.33%221,978-44.39%2.95%10.47%--1-50.00%
31 Mar, 223-40.00%399,173-9.11%5.31%5.17%--100.00%2-
31 Dec, 215-439,206-10.14%-5---

Bionomics Insider Shareholders Trades

Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jul 12, 2024Davies Peter Miles Winstondirector-Sell---269,984
Jul 08, 2024Ryan Janedirector-Sell100,000$0.15$15.19K-
Jul 08, 2024Wilson David Iandirector-Sell---251,939
Jul 08, 2024Wilson David Iandirector-Sell100,000$0.29$28.66K-
Jul 08, 2024Fisher Alandirector-Sell---100,000
Jul 08, 2024Fisher Alandirector-Sell100,000$0.23$23.49K-
Jul 08, 2024Papapetropoulos Spyrosdirector, officer Chief Executive OfficerSell---5,999,940
Jul 08, 2024Papapetropoulos Spyrosdirector, officer Chief Executive OfficerSell1,691,688$0.03$54.30K-

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jul 12, 2024Davies Peter Miles Winstondirector-Sell---269,984
Jul 08, 2024Cunningham Timothy M.officer-Buy----
Jul 08, 2024Ryan Janedirector-Sell100,000$0.15$15.19K-
Jul 08, 2024Wilson David Iandirector-Sell---251,939
Jul 08, 2024Wilson David Iandirector-Sell100,000$0.29$28.66K-
Jul 08, 2024Fisher Alandirector-Sell---100,000
Jul 08, 2024Fisher Alandirector-Sell100,000$0.23$23.49K-
Jul 08, 2024Weaver Aaron Ngoc Dungdirector Buy----
Jul 08, 2024Papapetropoulos Spyrosdirector, officer Chief Executive OfficerSell---5,999,940
Jul 08, 2024Papapetropoulos Spyrosdirector, officer Chief Executive OfficerSell1,691,688$0.03$54.30K-

The last insider sell of Bionomics's stock was made by Davies Peter Miles Winston on Jul 12 2024, selling - shares at - per share (valued at -).

Bionomics Insider Ownership Trends

All Insider Trades Trend

DateBuySellBuy/Sell Ratio

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio

Bionomics Peer Ownership

TickerCompany
PMVPPMV Pharmaceuticals, Inc.
AVTEAerovate Therapeutics, Inc.
ACRVAcrivon Therapeutics, Inc. Common Stock
SPRCSciSparc Ltd.
HILSTharimmune, Inc.
ANTXAN2 Therapeutics, Inc.
RZLTRezolute, Inc.
ANEBAnebulo Pharmaceuticals, Inc.
ADAGAdagene Inc.

BNOX Ownership FAQ

Bionomics is owned by institutional shareholders (23.90%), insiders (55.91%), and public (20.19%). The largest institutional shareholder of Bionomics is ARMISTICE CAPITAL, LLC (12.93% of total shares) and the top mutual fund owner is (0% of total shares).

Bionomics's major institutional shareholders are ARMISTICE CAPITAL, LLC, LYNX1 CAPITAL MANAGEMENT LP, POINT72 ASSET MANAGEMENT, L.P., UBS GROUP AG, and TWO SIGMA SECURITIES, LLC. The top five shareholders own together 23.23% of the company's share outstanding.

As of Jun 2024, there are 13 institutional shareholders of Bionomics.

ARMISTICE CAPITAL, LLC owns 1.23M shares of Bionomics, representing 12.93% of the company's total shares outstanding, valued at $940.92K (as of Jun 2024).

As of Jun 2024, LYNX1 CAPITAL MANAGEMENT LP holds 599.67K shares of Bionomics (BNOX), compromising 6.32% of the company, valued at $459.95K.

POINT72 ASSET MANAGEMENT, L.P is the third largest holder of Bionomics. The company owns 316K of the company's shares outstanding (worth $242.37K).